You appear to be offline. Some data may be unavailable until your connection is restored.
Description
AbbVie Inc. is a global specialty biopharmaceutical company that discovers, develops, manufactures and markets medicines for complex and serious diseases, focusing on therapeutic areas such as immunology, oncology, neuroscience, eye care and aesthetics. Its business model relies on a portfolio of patented biologics and small‑molecule drugs—including well‑known products like Humira, Imbruvica and Botox—supported by contract manufacturing services and worldwide commercial operations. Formed in 2012 as a spin‑off from Abbott Laboratories, AbbVie is among the largest biomedical firms by revenue and is a component of major U.S. indices, reflecting a strong market position in the pharmaceutical sector.
Stay on top of ABBV news
Subscribe to ABBV for a personalized daily news feed and a morning digest delivered to your inbox, plus alerts when its coverage turns bullish or bearish. For information only, not a recommendation.